Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer’s Disease?

Neurotherapeutics- United States

doi 10.1007/s13311-018-0668-6

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Parent Abuse: Can Law Be the Answer?

Social Policy and Society
SociologyInternational RelationsPolitical Science
2012English

Can Small Molecule Inhibitors of Glutaminyl Cyclase Be Used as a Therapeutic for Alzheimer's Disease?

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2017English

Can Arginase Be a Marker of the Large Bowel Neoplasia?

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
1993English

Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer’s Disease

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2019English

Archaeological Site Monitoring: Uav Photogrammetry Can Be an Answer

ISPRS - International Archives of the Photogrammetry, Remote Sensing and Spatial Information Sciences
2012English

Can Poor Sleep Cause Kidney Disease? Another Step Closer to the Answer

Journal of Clinical Sleep Medicine
PulmonaryNeurologyRespiratory Medicine
2019English

Can Abortion Mortality Be Eliminated? We Believe the Answer Is Yes

Journal of Human Growth and Development
Life-course StudiesLife-span
2015English

To Be AND Not to Be – Is That the Answer?

English

Arginase Inhibition Supports Survival and Differentiation of Neuronal Precursors in Adult Alzheimer’s Disease Mice

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy